Roberto Boffi Selected Research

Roberto Boffi Research Topics

7	Neoplasms (Cancer) 07/2022 - 03/2002
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 06/2009
3	COVID-19 01/2023 - 01/2020
3	Asthma (Bronchial Asthma) 01/2023 - 06/2009
2	Lung Neoplasms (Lung Cancer) 11/2022 - 12/2002
2	Tobacco Use Disorder (Nicotine Dependence) 12/2017 - 09/2013
1	Lung Diseases (Lung Disease) 01/2021
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Burns 09/2018
1	Obesity 01/2017
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2017
1	Pain (Aches) 01/2016
1	Stomatitis 01/2016
1	Oropharyngeal Neoplasms 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2015
1	Obstructive Lung Diseases (Obstructive Lung Disease) 06/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2002

3	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2023 - 11/2020
2	Particulate MatterIBA 12/2022 - 01/2014
2	Varenicline (Chantix)FDA Link 03/2020 - 02/2015
2	Opioid Analgesics (Opioids)IBA 01/2016 - 03/2002
1	N 30IBA 01/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2022
1	Nitrogen DioxideIBA 12/2022
1	cytisineIBA 11/2022
1	Immune Checkpoint InhibitorsIBA 07/2022
1	VaccinesIBA 01/2020
1	Formaldehyde (Formol)FDA Link 09/2018
1	CarcinogensIBA 09/2018
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017
1	FructoseIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	SmokeIBA 06/2016
1	Nicotine FDA Link 01/2014
1	Carbon MonoxideIBA 09/2013
1	SteroidsIBA 06/2009
1	Therapeutic UsesIBA 06/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2002
1	AntiemeticsIBA 03/2002

3	Therapeutics 11/2022 - 03/2002
1	Drug Therapy (Chemotherapy) 01/2017
1	Chemoradiotherapy 01/2016
1	Radiotherapy 12/2002
1	Palliative Care (Palliative Therapy) 03/2002